ClinicalTrials.Veeva

Menu

Neurofibromatosis Type 1 Patient Registry (NPRI)

The Washington University logo

The Washington University

Status

Completed

Conditions

Neurofibromatosis Type 1

Study type

Observational

Funder types

Other

Identifiers

NCT01410006
10-1036

Details and patient eligibility

About

The Neurofibromatosis Type 1 (NF1) Patient Registry Initiative (NPRI) is a web-based registry that asks participants to fill out a 30-minute online questionnaire to collect information about the spectrum of medical and social problems experienced by children and adults with NF1. The information gained from your participation may one day help doctors develop personalized treatments for individuals living with NF1.

We are currently enrolling individuals with NF1 who either (1) HAVE previously been diagnosed with a brain tumor younger than 18 years or (2) HAVE NEVER had a brain tumor. Please note: there is no therapy associated with this study. Individuals may participate in the registry by going to https://nf1registry.wustl.edu/

Enrollment

2,391 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals diagnosed by a healthcare provider with Neurofibromatosis Type 1

Exclusion criteria

  • Individuals without a healthcare provider diagnosis of Neurofibromatosis Type 1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems